Literature DB >> 17498220

Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?

Soo-Jeong Cho1, Jung-Hwan Yoon, Seung-Sik Hwang, Hyo-Suk Lee.   

Abstract

BACKGROUND AND AIM: The risk of hepatocellular carcinoma (HCC) is known to be age dependent; the influence of age on prognosis is, however, controversial. The aim of this study was to compare the tumor characteristics and survival rates of young and old HCC patients, with respect to tumor stage.
METHODS: We reviewed the clinical data and survival times of 71 young HCC patients from 1987 to 2003 and compared these with those of their older counterparts (n = 239). Patients were categorized into three age groups: group A, age <30 years (n = 71); group B, age >/=30 to <61 years (n = 168); and group C, age >/=61 years (n = 81). Kaplan-Meier methods and Cox proportional hazards regression were used to analyze survival.
RESULTS: The overall survival time of group A was shorter than groups B or C (P = 0.0071). Survival was not different in the three groups in subgroup analysis according to several tumor staging systems (e.g. Japan Integrated Staging score, Cancer of the Liver Italian Program scoring system and Barcelona Clinic Liver Cancer staging classification). The multivariate hazard ratio of group B was 0.840 (95% confidence interval [CI] 0.490-1.440) and that of group C was 0.770 (95% CI 0.410-1.446) in reference to group A.
CONCLUSIONS: Young HCC patients showed a poorer prognosis than older HCC patients because they have a more advanced tumor stage at diagnosis. However, age was not an independent prognostic factor when stages were matched. Therefore, we suggest that periodic surveillance in young chronic hepatitis B virus carriers would improve outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17498220     DOI: 10.1111/j.1440-1746.2007.04914.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  30 in total

1.  Surgical outcomes and clinical characteristics of elderly patients undergoing curative hepatectomy for hepatocellular carcinoma.

Authors:  Fumitoshi Hirokawa; Michihiro Hayashi; Yoshiharu Miyamoto; Mitsuhiro Asakuma; Tetsunosuke Shimizu; Koji Komeda; Yoshihiro Inoue; Atsushi Takeshita; Yuro Shibayama; Kazuhisa Uchiyama
Journal:  J Gastrointest Surg       Date:  2013-09-04       Impact factor: 3.452

2.  Clinicopathological features and outcomes of young patients with hepatocellular carcinoma after hepatectomy.

Authors:  Kazuki Takeishi; Ken Shirabe; Jun Muto; Takeo Toshima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  World J Surg       Date:  2011-05       Impact factor: 3.352

Review 3.  Management of hepatocellular carcinoma in the elderly.

Authors:  Mauro Borzio; Elena Dionigi; Giancarlo Parisi; Ivana Raguzzi; Rodolfo Sacco
Journal:  World J Hepatol       Date:  2015-06-18

4.  A comparative analysis of hepatocellular carcinoma after hepatic resection in young versus elderly patients.

Authors:  Cho Rok Lee; Jin Hong Lim; Sung Hoon Kim; Sang Hoon Ahn; Young Nyun Park; Gi Hong Choi; Jin Sub Choi; Kyung Sik Kim
Journal:  J Gastrointest Surg       Date:  2012-07-19       Impact factor: 3.452

5.  The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC).

Authors:  Hilda Wong; Yuen Fong Tang; Tzy-Jyun Yao; Joanne Chiu; Roland Leung; Pierre Chan; Tan To Cheung; Albert C Chan; Roberta W Pang; Ronnie Poon; Sheung-Tat Fan; Thomas Yau
Journal:  Oncologist       Date:  2011-12-01

6.  Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.

Authors:  Brian I Carr; Petr Pancoska; Robert A Branch
Journal:  Hepatol Int       Date:  2009-12-24       Impact factor: 6.047

7.  Family history influences the early onset of hepatocellular carcinoma.

Authors:  Chung-Hwa Park; Seung-Hee Jeong; Hyeon-Woo Yim; Jin Dong Kim; Si Hyun Bae; Jong Young Choi; Seung Kew Yoon
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 8.  Targeted therapy for advanced hepatocellular cancer in the elderly: focus on sorafenib.

Authors:  D Germano; V Tinessa; E Barletta; L Cannella; B Daniele
Journal:  Drugs Aging       Date:  2013-11       Impact factor: 3.923

9.  Is the prognosis of young patients with hepatocellular carcinoma poorer than the prognosis of older patients? A comparative analysis of clinical characteristics, prognostic features, and survival outcome.

Authors:  Pik-Eu Chang; Wai-Choung Ong; Hock-Foong Lui; Chee-Kiat Tan
Journal:  J Gastroenterol       Date:  2008-11-18       Impact factor: 7.527

10.  Different patterns in the prognostic value of age for bladder cancer-specific survival depending on tumor stages.

Authors:  Huan Feng; Wei Zhang; Jiajun Li; Xiaozhe Lu
Journal:  Am J Cancer Res       Date:  2015-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.